Clyde & Co advised Mr. Dimitris Spyridis on part sale of his minority stake in Hellenic Healthcare

Clyde & Co advised Mr. Dimitris Spyridis on the part sale of his minority stake in Hellenic Healthcare Group (“HHG”), the largest private healthcare provider in Greece and Cyprus, to PureHealth Holding PJSC (“PureHealth”), the largest healthcare group in the Middle East, in a transaction that values HHG at EUR 2.3 billion.

HHG is currently owned 90% by CVC Capital Partners VI and 10% by Mr Dimitris Spyridis, HHG CEO. PureHealth will acquire a 60% stake in HHG, with CVC Capital Partners VI retaining 35% ownership, while CEO and founder, Mr Dimitris Spyridis, will retain a 5% stake in the company.

HHG has rapidly positioned itself as a leading provider in European healthcare in Greece and Cyprus, delivering advanced medical services across a network of 10 hospitals and 16 diagnostic centres across Greece and Cyprus. With a capacity of over 1,600 beds, the group serves approximately 1.4 million patients annually through a team of more than 6,700 healthcare professionals. HHG offers a full spectrum of medical specialties with expertise in complex fields such as oncology, cardiology, and neurosurgery, along with services including IVF treatments performing over 6,000 cycles annually and comprehensive homecare services. PureHealth partnering with CVC in healthcare investments shows strength in PureHealth's international expansion plan

“It has been our pleasure to work with Mr. Dimitris Spyridis since the original investment by CVC into HHG and now with PureHealth”  Simon Gamblin, Partner.

The Clyde & Co team was led by Corporate Partner, Simon Gamblin, and Legal Director, Ben Chalkley, with the assistance of Associates, Daniel Li and Nii-Lante Bannerman.

The closing of the transaction is subject to regulatory approvals and customary closing conditions.